Drug Profile
ET 007
Alternative Names: Anti-HIV drug - Endocrine Technology; HIV antiviral drug - Endocrine TransplantLatest Information Update: 24 Apr 2007
Price :
$50
*
At a glance
- Originator Endocrine Technology LLC
- Class
- Mechanism of Action HIV envelope protein gp120 inhibitors; HIV envelope protein gp41 inhibitors; Human immunodeficiency virus tat gene product inhibitors; Immunostimulants; RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 24 Apr 2007 Discontinued - Preclinical for HIV infections prevention in USA (unspecified route)
- 24 Apr 2007 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
- 18 Feb 2002 Preclinical development for HIV infections prevention in USA (Unknown route)